Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidong Yixin Granules for Prevention of Atrial Fibrillation Recurrence After Ablation
NCT07508618Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Feb 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Qidong Yixin Granules in Atrial fibrillation (AFib), sponsored by Sir Run-Run Shaw Hospital. Started Feb 2026; status: recruiting.
02
Drugs
Qidong Yixin Granules
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07508618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07508618.